ArticleKidney international reports2024

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy.

Mieke van Schaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.